BioAge

BioAge is a clinical-stage biotechnology company that develops drugs to treat aging and aging-related diseases.

Industries

Biotechnology, Education

Headquarters

Richmond, United States

Stage

Series C

Employees

11-50

Links

Org chart

Kristen Fortney

Co-Founder & CEO

Collapse

Eric Morgen

Co-Founder & COO

Dov Goldstein

CFO

Peng Leong

Chief Business Officer & Therapeutic Area Head, Brain Aging

Ann Neale

Chief Development Officer

BJ Sullivan

Chief of Staff

Paul Rubin

EVP, Research & CMO

Carrie-Lynn Langlais Furr

SVP, Regulatory Affairs

Julie Gammelgard

SVP, People

Sabine Vukelich

SVP, Regulatory Affairs & QA

VP, Biochemistry

VP, Biology

VP, Media

VP, CMC

VP, Data Science

VP, Translational Aging Biology

Teams

View all

+11

Board of Directors

14 members

Leadership Team

11 members

CEO and Executive Team

7 members

Founding Team

2 members

Discover similar companies

Voyager Therapeutics

Cambridge, United States · Post IPO Equity

Volastra

Boston, United States · Series A

Aspen Neuroscience

San Diego, United States · Debt Financing

AllStripes

San Francisco, United States · Series B

Mission Bio

San Francisco, United States · Series C

Korro Bio

Cambridge, United States · Series B

Illumina

San Diego, United States

MassBio

Cambridge, United States

CytomX

South San Francisco, United States

Axsome Therapeutics

New York, United States · Post IPO Equity

Cue Biopharma

Cambridge, United States · Post IPO Equity

Allakos

San Carlos, United States · Post IPO Equity

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.